Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cytotherapy

• Publication date

  2011-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/14653249.2011.592521PMID 21736505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy for amyotrophic lateral sclerosis.

  2012cited by this paper
• The neurobiology of amyotrophic lateral sclerosis

  2010cited by this paper
• Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.

  2010cited by this paper
• Distribution, Differentiation, and Survival of Intravenously Administered Neural Stem Cells in a Rat Model of Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis

  2009cited by this paper
• Biomarkers in amyotrophic lateral sclerosis.

  2009cited by this paper
• Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival

  2009cited by this paper
• Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.

  2008cited by this paper
• Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose

  2008cited by this paper
• Vascular Endothelial Growth Factor Overexpression Delays Neurodegeneration and Prolongs Survival in Amyotrophic Lateral Sclerosis Mice

  2007cited by this paper
• Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.

  2007cited by this paper
• REVIEW ARTILCE: Cell therapy and stem cells in animal models of motor neuron disorders

  2007cited by this paper
• Sodium Valproate Exerts Neuroprotective Effects In Vivo through CREB-Binding Protein-Dependent Mechanisms But Does Not Improve Survival in an Amyotrophic Lateral Sclerosis Mouse Model

  2007cited by this paper
• Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS

  2007cited by this paper
• Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects

  2007cited by this paper
• Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2006cited by this paper
• Abstract 3685: Intracoronary Infusion of Bone-Marrow-Derived Progenitor Cells is Associated with Improved Clinical Outcome in Patients with Acute Myocardial Infarction: 12 Months Follow Up of the REPAIR-AMI Trial

  2006cited by this paper
• Transplantation of Bone Marrow Stem Cells as well as Mobilization by Granulocyte-Colony Stimulating Factor Promotes Recovery after Spinal Cord Injury in Rats

  2006cited by this paper
• Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis.

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial.

  2006cited by this paper
• Mesenchymal stem cells as trophic mediators

  2006cited by this paper
• Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

  2005cited by this paper
• Autologous mesenchymal stem cell transplantation in stroke patients

  2005cited by this paper
• Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

  2004cited by this paper
• Stem-cell therapy in amyotrophic lateral sclerosis.

  2004cited by this paper
• Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells

  2004cited by this paper
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004cited by this paper
• Stem-cell therapy for amyotrophic lateral sclerosis.

  2004cited by this paper
• Immunomodulatory effects of fetal and adult mesenchymal stem cells.

  2003cited by this paper
• AUTOLOGOUS ADULT BONE MARROW STEM CELL TRANSPLANTATION IN AN ANIMAL MODEL OF HUNTINGTON'S DISEASE: BEHAVIORAL AND MORPHOLOGICAL OUTCOMES

  2003cited by this paper
• Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

  2003cited by this paper
• Immunomodulatory effects of fetal and adult mesenchymal stem cells.

  2003cited by this paper
• Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery

  2002cited by this paper
• Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists

  2002cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.

  2000cited by this paper
• Diagnosis of amyotrophic lateral sclerosis.

  1998cited by this paper
• Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis.

  1997cited by this paper
• ‘Green mice’ as a source of ubiquitous green cells

  1997cited by this paper
• A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in Rats

  1995cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Estimate of the total number of neurons and glial and endothelial cells in the rat spinal cord by means of the optical disector

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper

• Mesenchymal Stem Cell-Based Therapies Applied in Neurological Diseases: A Systematic Review.

  2026cites this paper
• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

  2024cites this paper
• Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives

  2023cites this paper
• Silk fibroin carriers with sustained release capacity for treating neurological diseases

  2023cites this paper
• Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications

  2023cites this paper
• Stem Cell-Based Therapeutic Approaches in Genetic Diseases.

  2023cites this paper
• Cell therapy as a treatment strategy in amyotrophic lateral sclerosis

  2022cites this paper
• Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects

  2022cites this paper
• Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn

  2022cites this paper
• Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases

  2022cites this paper
• Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects

  2022cites this paper
• Cell-based Research and Therapy for Amyotrophic Lateral Sclerosis: Promises and Challenges

  2021cites this paper
• Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis

  2021cites this paper
• Mesenchymal Stem Cells for Neurological Disorders

  2021cites this paper
• Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis

  2021cites this paper
• Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis

  2020cites this paper
• Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?

  2020cites this paper
• Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.

  2020cites this paper
• Transplantation of Neural Precursors Derived from Induced Pluripotent Cells Preserve Perineuronal Nets and Stimulate Neural Plasticity in ALS Rats

  2020cites this paper
• Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?

  2019cites this paper
• Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes.

  2019cites this paper
• Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

  2019cites this paper
• Safety and Biodistribution of Human Bone Marrow-Derived Mesenchymal Stromal Cells Injected Intrathecally in Non-Obese Diabetic Severe Combined Immunodeficiency Mice: Preclinical Study

  2019cites this paper
• A Comprehensive Review on the Application of Mesenchymal Stem Cell in the Treatment of ALS Patients

  2018cites this paper
• A Review of Stem Cell Therapy for Acquired Brain Injuries and Neurodegenerative Central Nervous System Diseases

  2018cites this paper
• Transplantation of Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial

  2017cites this paper
• The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy – a perspective on cell biological mechanisms

  2017cites this paper
• Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside

  2017cites this paper
• Chapter 9 – Stem Cell Therapy for Amyotrophic Lateral Sclerosis

  2017cites this paper
• ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles

  2017cites this paper
• Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation.

  2016cites this paper
• CNS Regenerative Medicine and Stem Cells

  2016cites this paper
• Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging

  2016cites this paper
• Stem Cells for Amyotrophic Lateral Sclerosis

  2016cites this paper
• Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.

  2016cites this paper
• Mesenchymal Stem Cells Preserve Working Memory in the 3 xTg-AD Mouse Model of Alzheimer ’ s Disease

  2016cites this paper
• Speci fi c pro fi les of ion channels and ionotropic receptors de fi ne adipose-and bone marrow derived stromal cells

  2016cites this paper
• Specific profiles of ion channels and ionotropic receptors define adipose- and bone marrow derived stromal cells.

  2016cites this paper
• Transplantation of bone marrow mononuclear cells prolongs survival, delays disease onset and progression and mitigates neuronal loss in pre-symptomatic, but not symptomatic ALS mice.

  2016cites this paper
• Physiology of Ca(2+) signalling in stem cells of different origins and differentiation stages.

  2016cites this paper
• Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis

  2015cites this paper
• Stem cell therapy for amyotrophic lateral sclerosis

  2015cites this paper
• Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.

  2014cites this paper
• Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

  2014cites this paper
• Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold.

  2014cites this paper
• Mesenchymal stem cell therapy for neurodegenerative diseases.

  2014cites this paper
• Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?

  2014cites this paper
• Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS

  2014cites this paper
• In vivo tracking of neuronal-like cells by magnetic resonance in rabbit models of spinal cord injury

  2013cites this paper
• Clinical experience with stem cells and other cell therapies in neurological diseases.

  2013cites this paper
• Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System

  2013cites this paper
• Human mesenchymal stem cells in the treatment of neurological diseases.

  2013cites this paper
• Stem cells in regenerative medicine.

  2013cites this paper
• The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis

  2013cites this paper
• The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.

  2013cites this paper
• Translational Research in Stem Cell Treatment of Neuromuscular Diseases

  2013cites this paper
• POTENCIAL TERAPÊUTICO DAS CÉLULAS MONONUCLEARES DA MEDULA ÓSSEA EM UM MODELO EXPERIMENTAL DE ESCLEROSE LATERAL AMIOTRÓFICA

  2012cites this paper
• Mesenchymal Stromal Cells and Neural Stem Cells Potential for Neural Repair in Spinal Cord Injury and Human Neurodegenerative Disorders

  2012cites this paper
• Cultivating stem cells for treating amyotrophic lateral sclerosis.

  2012cites this paper
• Transplantation of mesenchymal stem cells in ALS.

  2012cites this paper
• Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury

  2012cites this paper
• Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.

  2012cites this paper
• Autologous stem cells in neurology: is there a future?

  2012cites this paper
• Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis – Scientific Truth should Rely on Facts, but Not Conjecture

  2011cites this paper